GLP-1s might be the closest weve come, but the big question is, do they really work in the long run
Similarly, an analysis utilizing the UK Clinical Practice Research Datalink (CPRD) revealed that GLP-1 RAs were linked to an increased incidence of intestinal obstruction requiring hospitalization, compared to sodium-glucose cotransporter-2 (SGLT-2) inhibitors (1.9 vs
Some people also find that getting up to move after eating is helpful
The majority of GLP-1 medications are only approved for adults 18 years and older
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and titrated upward based on therapeutic response and tolerability
At Doctor Tony Clinic, we recommend starting with a lower dosage and gradually increasing it as your body becomes accustomed to the treatment